Ashok Leyland April 2026 Total Sales Rise 9% YoY, Miss Estimate of 15,800 Units

2 min read     Updated on 04 May 2026, 09:29 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Ashok Leyland reported April 2026 total vehicle sales (domestic + exports) of 14,646 units, up 9% YoY from 13,421 units but below the analyst estimate of 15,800 units. Domestic sales rose 14% YoY to 14,242 units, driven by strong LCV growth of 23% YoY and M&HCV Trucks growth of 15% YoY, while M&HCV Bus volumes declined sharply by 22% domestically and 30% on a combined basis.

powered bylight_fuzz_icon
39411749

*this image is generated using AI for illustrative purposes only.

Ashok Leyland has released its monthly sales figures for April 2026 under Regulation 30 (Disclosure of Events or Information) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was communicated to the stock exchanges on May 4, 2026, and covers unit sales across key vehicle categories for the domestic market as well as combined domestic and export volumes. While total vehicle sales (domestic and exports) grew 9% year-on-year to 14,646 units, the figure fell short of the analyst estimate of 15,800 units.

Domestic Sales Performance

Ashok Leyland's domestic vehicle sales for April 2026 registered a 14% year-on-year increase, reaching 14,242 units compared to 12,509 units in April 2025. The growth was broad-based across most segments, with M&HCV Trucks and LCVs posting notable gains, partially offset by a decline in M&HCV Bus volumes.

The table below summarises domestic sales performance by category:

Category: Apr'26 Apr'25 Inc/(Dec)
M&HCV Trucks: 6,814 5,915 15%
M&HCV Bus: 1,163 1,491 (22%)
Total M&HCV: 7,977 7,406 8%
LCV: 6,265 5,103 23%
Total Vehicles: 14,242 12,509 14%

Domestic M&HCV Trucks grew 15% YoY to 6,814 units from 5,915 units, while the LCV segment recorded the strongest growth at 23% YoY, rising to 6,265 units from 5,103 units. M&HCV Bus volumes, however, declined 22% YoY to 1,163 units from 1,491 units. Overall domestic M&HCV sales (trucks and buses combined) increased 8% YoY to 7,977 units.

Combined Domestic and Export Sales Performance

On a combined domestic and exports basis, Ashok Leyland's total vehicle sales for April 2026 grew 9% YoY to 14,646 units, up from 13,421 units in April 2025, missing the analyst estimate of 15,800 units. The following table provides a breakdown of combined sales figures:

Category: Apr'26 Apr'25 Inc/(Dec)
M&HCV Trucks: 7,007 6,119 15%
M&HCV Bus: 1,295 1,841 (30%)
Total M&HCV: 8,302 7,960 4%
LCV: 6,344 5,461 16%
Total Vehicles: 14,646 13,421 9%

M&HCV Trucks on a combined basis rose 15% YoY to 7,007 units from 6,119 units, and LCV sales increased 16% YoY to 6,344 units from 5,461 units. M&HCV Bus volumes on a combined basis declined 30% YoY to 1,295 units from 1,841 units. Total M&HCV (combined) grew 4% YoY to 8,302 units from 7,960 units.

Key Highlights

  • Combined total vehicles up 9% YoY to 14,646 units (Apr'25: 13,421 units) vs. estimate of 15,800 units
  • Domestic total vehicles up 14% YoY to 14,242 units (Apr'25: 12,509 units)
  • M&HCV Trucks (domestic) grew 15% YoY to 6,814 units
  • LCV (domestic) posted the highest growth at 23% YoY, reaching 6,265 units
  • M&HCV Bus (domestic) declined 22% YoY to 1,163 units
  • M&HCV Bus (combined) declined 30% YoY to 1,295 units

The sales disclosure was signed by N. Ramanathan, Company Secretary of Ashok Leyland, and submitted to both the National Stock Exchange of India Limited and BSE Limited on May 4, 2026.

Historical Stock Returns for Ashok Leyland

1 Day5 Days1 Month6 Months1 Year5 Years
-0.32%-5.35%+7.96%+14.11%+42.95%+189.26%

What structural factors are driving the sustained 22-30% YoY decline in M&HCV Bus volumes, and could government fleet electrification or KSRTC/STU budget constraints prolong this weakness through FY27?

Given that combined sales missed analyst estimates by nearly 8%, how might Ashok Leyland's management revise its full-year volume guidance, and what impact could this have on FY27 revenue and margin forecasts?

With LCV domestic sales surging 23% YoY, is this growth sustainable amid rising competition from Tata Motors and new entrants, or is it partly driven by pre-buying ahead of regulatory or pricing changes?

Morgan Stanley Sets Equal-Weight Rating on Ashok Leyland with ₹180 Target Price

1 min read     Updated on 29 Apr 2026, 08:57 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Morgan Stanley has issued an Equal-weight rating with tactical sell recommendation on Ashok Leyland, setting a ₹180 target price. The brokerage expects near-term underperformance after the stock's 20% rally, citing concerns over CV growth tapering in 2HFY27, rising commodity costs pressuring margins, and less attractive valuations at 13x FY27 EV/EBITDA ex-HLF. The firm maintains a high 70-80% negative scenario probability for the stock.

powered bylight_fuzz_icon
38978858

*this image is generated using AI for illustrative purposes only.

Ashok Leyland faces a cautious outlook from Morgan Stanley, which has assigned an Equal-weight rating with a tactical sell recommendation and established a target price of ₹180. The global brokerage firm anticipates near-term underperformance from the commercial vehicle manufacturer following its recent strong rally.

Recent Performance and Market Context

The stock has experienced a significant rally of approximately 20% against the backdrop of a weak Nifty performance. However, Morgan Stanley believes this outperformance may not be sustainable in the near term, prompting their tactical sell stance despite the Equal-weight rating.

Growth and Margin Concerns

Morgan Stanley has identified several key challenges that could impact Ashok Leyland's performance:

Key Concerns Details
CV Growth Outlook Expected tapering in 2HFY27
Cost Pressures Rising commodity costs
Margin Impact Potential pressure on profitability
Negative Scenario Probability 70-80%

The brokerage expects commercial vehicle growth to taper during the second half of FY27, which could significantly impact the company's revenue trajectory. Additionally, rising commodity costs are anticipated to create margin pressures, potentially affecting the company's profitability metrics.

Valuation Assessment

Morgan Stanley's analysis indicates that Ashok Leyland's current valuations appear less compelling at approximately 13x FY27 EV/EBITDA excluding HLF (Hinduja Leyland Finance). This valuation metric suggests limited upside potential from current levels, supporting the firm's cautious stance on the stock.

Risk Assessment

The brokerage maintains a notably high negative scenario probability of 70-80% for Ashok Leyland, reflecting significant downside risks in their assessment. This elevated risk perception underscores the challenges facing the commercial vehicle sector and the company's specific operational environment.

The combination of growth concerns, margin pressures, and valuation considerations has led Morgan Stanley to recommend a tactical approach, suggesting investors may want to consider reducing exposure despite the Equal-weight rating.

Historical Stock Returns for Ashok Leyland

1 Day5 Days1 Month6 Months1 Year5 Years
-0.32%-5.35%+7.96%+14.11%+42.95%+189.26%

How might the anticipated CV growth tapering in 2HFY27 affect other major commercial vehicle manufacturers in the Indian market?

What specific commodity price trends could most significantly impact Ashok Leyland's margin recovery prospects over the next 12-18 months?

Will infrastructure spending announcements in the upcoming budget potentially alter Morgan Stanley's negative scenario probability assessment?

More News on Ashok Leyland

1 Year Returns:+42.95%